Vimarsana
Biggest News Aggregation in the World

Page 32 - Sciences Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sciences Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sciences Ltd Today - Breaking & Trending Today

dementia | Benzinga - Vimarsana News

dementia | Benzinga

Finnish Biotech company Biotie Therapies (NASDAQ: BITI) (OTC: BIOZF) hopes to raise $56 million in its upcoming IPO this Friday, June 12. The company will offer 3.8 ADSs at price of $14.82, up 12 percent from its original offer. The deal was initially set for 3.4 million ADSs at the same price... Read More... Don't Miss Any Updates! News Directly in Your Inbox Subscribe to:

RPG Life Sciences: Visible Improvement - Vimarsana News

RPG Life Sciences: Visible Improvement

RPG Life Sciences Ltd (RPGLS) makes a range of branded formulations and APIs

Small Caps Daily: SmallCapsDaily: Lobe Sciences is a Major Opportunity In the Psychedelics Medicine Industry - Vimarsana News

Small Caps Daily: SmallCapsDaily: Lobe Sciences is a Major Opportunity In the Psychedelics Medicine Industry

Small Caps Daily: SmallCapsDaily: Lobe Sciences is a Major Opportunity In the Psychedelics Medicine Industry New York, New York--(Newsfile Corp. - February 12, 2021) - Lobe Sciences Ltd., (OTC Pink: GTSIF), a growth-oriented research, technology & services company that provides financial, management, IP and branding support to businesses, which focuses on the development of psilocybin-based therapeutics for mental health applications, was recently the focus of coverage by leading financial news website and publisher, SmallCapsDaily. Lobe Sciences is carving out a significant space in the bur...

Class 4 Medicines Defect Information, AmBisome Liposomal 50 mg Powder for dispersion for infusion, (PL 16807/0001), EL (21)A/03 - Vimarsana News

Class 4 Medicines Defect Information, AmBisome Liposomal 50 mg Powder for dispersion for infusion, (PL 16807/0001), EL (21)A/03

Class 4 Medicines Defect Information, AmBisome Liposomal 50 mg Powder for dispersion for infusion, (PL 16807/0001), EL (21)A/03 Gilead Sciences Ltd has informed us of a quality defect issue, in relation to specific lots of 5µm sterile filters, which are co-packed in cartons of the AmBisome product. The medical device is called Minisart Filter 16534-K. From: Medical specialty: Brief description of the problem Gilead Sciences Ltd has informed us of a quality defect issue, in relation to specific lots of 5µm sterile filters, which are co-packed in cartons of the AmBisome product. The me...

Source: gov.uk
(MYOV) - Myovant Sciences: Q3 Earnings Insights - Vimarsana News

(MYOV) - Myovant Sciences: Q3 Earnings Insights

Shares of Myovant Sciences (NYSE:MYOV) moved higher by 0.3% in pre-market trading after the company reported Q3 results. Quarterly Results Earnings per ...